Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Sarcopenia and Cachexia in Patients With Lung Cancer
This clinical trial update indicates an ongoing study examining sarcopenia and cachexia in patients with lung cancer (both non-small cell an…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)] [Phase 2]
A Phase 2 trial evaluating the LBL-024 combination in patients with advanced solid tumours, including a sub-study in non-small cell lung can…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node Involvement [Phase 2]
A Phase 2 clinical trial investigating neoadjuvant chemo-immunotherapy followed by surgical resection for locally advanced non-small cell lu…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Stereotactic Body Radiotherapy (SBRT) for Reirradiation of Inoperable Lung Lesions
An ongoing clinical trial is evaluating stereotactic body radiotherapy (SBRT) as a reirradiation approach for inoperable lung lesions in non…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Neoadjuvant Platform Trial in Non-Small Cell Lung Cancer [Phase 2]
Phase 2 neoadjuvant platform trial in non-small cell lung cancer sponsored by the Canadian Cancer Trials Group; the study is currently activ…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC [Phase 2]
A Phase 2 clinical trial update evaluating Ivonescimab alone and in combination with carboplatin/pemetrexed for non-small cell lung cancer, …
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer [EARLY_Phase 1]
An early-phase 1 trial evaluating low-dose interleukin-2 in combination with pembrolizumab for stage IV non-small cell lung cancer is curren…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Preoperative Structured Exercise Programme on Patients With Non-Small Cell Lung Cancer [NA]
This document reports a clinical trial evaluating a preoperative structured exercise program for patients with Non-Small Cell Lung Cancer th…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AST2303 Tablets (ABK3376 Tablets) in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 study to evaluate safety, tolerability, pharmacokinetics, and preliminary efficacy of AST2303 (ABK3376) tablets in adults with loc…
-
EMA approval · 2026-02-11EMA Authorised: Imjudo (tremelimumab) — AstraZeneca AB
EMA has authorised Imjudo (tremelimumab) from AstraZeneca AB for hepatocellular carcinoma and non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: A Study of Calderasib (MK-1084) With Midazolam and Digoxin in Healthy Participants (MK-1084-009) [Phase 1]
Phase 1 study update of Calderasib (MK-1084) with Midazolam and Digoxin in healthy participants, status completed.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: IBI363 as Neoadjuvant Therapy in Resectable Stage II-III Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating IBI363 as neoadjuvant therapy for resectable stage II-III non-small cell lung cancer is listed, with status not y…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Prospective Phase II Clinical Study of Immunotherapy Combined With Chemotherapy for Stage III Unresectable Non-small Cell Lung Cancer [Phase 2]
A prospective Phase II study evaluating immunotherapy combined with chemotherapy for stage III unresectable non-small cell lung cancer is cu…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer [Phase 2]
This is a Phase 2 clinical trial evaluating adjuvant chemotherapy with or without cemiplimab and sequential hypofractionated radiotherapy in…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial update evaluating sacituzumab govitecan combinations as first-line therapy for advanced or metastatic non-small cell lung canc…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC [Phase 1]
Phase 1 trial of novel anti-cancer agents in patients with metastatic non-small cell lung cancer; the study is active but not currently recr…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib [Phase 2]
Phase 2 study evaluating osimertinib plus savolitinib for EGFR-mutant, MET-positive non-small cell lung cancer after prior osimertinib, with…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of MCLA-129, a bispecific EGFR and cMet antibody, in advanced non-small cell lung cancer and other solid tumors, currently r…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 Levels [Phase 2]
A Phase 2 trial is evaluating immunotherapy without chemotherapy for advanced non-small cell lung cancer with high PD-L1 expression; the stu…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Korea Post Marketing Surveillance (PMS) Study of Vizimpro
Pfizer reports the completion of the Korea post-marketing surveillance study of Vizimpro (dacomitinib) for non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Post-operative Radiotherapy After Neodjuvant Chemo-immunotherapy and Surgery in Stage III NSCLC [Phase 2]
A Phase II clinical trial recruiting to evaluate postoperative radiotherapy after neoadjuvant chemo-immunotherapy and surgery in stage III n…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E) [Phase 2]
ADAPT-E is a Phase 2 clinical trial evaluating adjuvant ctDNA–guided, personalized treatment for early-stage non-small cell lung cancer and …
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: A ctDNA-guided Phase II Trial of Osimertinib in Combination With Sacituzumab Tirumotecan in EGFR-mutated Advanced NSCLC Patients With Positvie ctDNA After lead-in Osimertinib Monotherapy [Phase 2]
A Phase II ctDNA-guided trial evaluating the combination of osimertinib with sacituzumab govitecan in EGFR-mutated advanced non-small cell l…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Anlotinib in Cross-line Treatment of NSCLC and SCLC
This clinical trial update shows that anlotinib is being evaluated for cross-line treatment of advanced non-small cell lung cancer and exten…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
This clinical trial update analyzes clinical outcomes and genomic data from American Indian patients across several cancer indications, with…